Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Approximately one in six children and young people with spinal muscular atrophy (SMA) have abnormal sleep, according to a study published in the scientific journal Sleep Medicine. An additional one ... Read more
Nusinersen, an investigational drug for the treatment of spinal muscular atrophy (SMA) is acceptably safe and well tolerated, and shows encouraging clinical efficacy according to a study published in the ... Read more
Developmental milestones such as sitting unaided, rolling, crawling, standing or walking are rarely, even partially achieved by infants with type 1 spinal muscular atrophy (SMA), confirms a study published in ... Read more
A team of international researchers developed a revised upper limb module (RULM) to assess arm function in people with spinal muscular atrophy (SMA), which can capture progressive muscle weakness even ... Read more